Health CanadaGeneral Alert
XOFIGO® (radium Ra 223 dichloride) - Increased Incidence of Fractures and Trend ...
Published: November 8, 2018Recall ID: 58484Category: generalCountry: Canada
Reason for Recall / Hazard
Product safety
Product Description & Identification
XOFIGO® (radium Ra 223 dichloride) - Increased Incidence of Fractures and Trend for Increased Deaths with XOFIGO used in combination with abiraterone and prednisone/prednisolone
Additional Source Details
| Field | Value |
|---|---|
| N I D | 58484 |
| U R L | https://recalls-rappels.canada.ca/en/alert-recall/xofigor-radium-ra-223-dichloride-increased-incidence-fractures-and-trend-increased |
| Issue | Product safety |
| Title | XOFIGO® (radium Ra 223 dichloride) - Increased Incidence of Fractures and Trend for Increased Deaths with XOFIGO used in combination with abiraterone and prednisone/prednisolone |
| Archived | 0 |
| Category | Biologic or vaccine |
| Last updated | 2018-11-08 |
| Organization | Marketed health products |